The di-flavoenzyme reductase directly activates oxygen for the metabolism of diverse drug molecules by liver microsomal Cytochrome P450s

2006/10/19 by Kelath Murali Manoj, Manoj, Kelath Murali
Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · #Biomolecules (q-bio.BM) #Cancer, Hypoxia, and Metabolism #FOS: Biological sciences #Metabolomics and Mass Spectrometry Studies #Pharmacogenetics and Drug Metabolism #Subcellular Processes (q-bio.SC) #q-bio.BM #q-bio.SC

paper · pdf · doi:10.48550/arxiv.q-bio/0610036

This submission has been withdrawn by arXiv administration

openalex publication_date 2006/10/19 · arxiv created 2006/12/19 · arxiv updated 2009/12/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Abstract

This submission has been withdrawn by arXiv administration due to complaints of misuse of institutional affiliation.

Related

• Asymmetry of rotational catalysis of single membrane-bound F0F1-ATP synthase
• The regulatory potential of cytochrome P450-adrenodoxin interactions: Insights toward understanding redox partner regulation in drug metabolizing enzymes
• Reconstitution of Human Cytochrome P450 Activity using a Leishmania Cell-Free Protein Expression System
• REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION
• The Central Role of Cytochrome P450 in Xenobiotic Metabolism—A Brief Review on a Fascinating Enzyme Family